In their study, the difference in PFS across DS stages was markedly significant, while the impact on OS was only modest [30] .
← all excerpts
[<sup>18</sup>F]FDG-PET/CT in DLBCL-patients treated with CAR-T cell therapy: potential for defining patient prognosis.
1
—
—